Casanova A - Search Results

1

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.

Figarol S, Delahaye C, Gence R, Doussine A, Cerapio JP, Brachais M, Tardy C, Béry N, Asslan R, Colinge J, Villemin JP, Maraver A, Ferrer I, Paz-Ares L, Kessler L, Burrows F, Lajoie-Mazenc I, Dongay V, Morin C, Florent A, Pagano S, Taranchon-Clermont E, Casanova A, Pradines A, Mazieres J, Favre G, Calvayrac O. Figarol S, et al. Among authors: casanova a. Nat Commun. 2024 Jun 27;15(1):5345. doi: 10.1038/s41467-024-49360-4. Nat Commun. 2024. PMID: 38937474 Free PMC article.

2

Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization.

Tillement V, Lajoie-Mazenc I, Casanova A, Froment C, Penary M, Tovar D, Marquez R, Monsarrat B, Favre G, Pradines A. Tillement V, et al. Among authors: casanova a. Exp Cell Res. 2008 Sep 10;314(15):2811-21. doi: 10.1016/j.yexcr.2008.06.011. Epub 2008 Jun 18. Exp Cell Res. 2008. PMID: 18590726

3

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

Bousquet E, Mazières J, Privat M, Rizzati V, Casanova A, Ledoux A, Mery E, Couderc B, Favre G, Pradines A. Bousquet E, et al. Among authors: casanova a. Cancer Res. 2009 Aug 1;69(15):6092-9. doi: 10.1158/0008-5472.CAN-08-4147. Epub 2009 Jul 14. Cancer Res. 2009. PMID: 19602596

4

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.

Calvayrac O, Pradines A, Raymond-Letron I, Rouquette I, Bousquet E, Lauwers-Cances V, Filleron T, Cadranel J, Beau-Faller M, Casanova A, Milia J, Favre G, Mazières J. Calvayrac O, et al. Among authors: casanova a. Clin Cancer Res. 2014 Dec 15;20(24):6541-50. doi: 10.1158/1078-0432.CCR-14-0506. Epub 2014 Oct 15. Clin Cancer Res. 2014. PMID: 25320360

5

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

Armand-Labit V, Meyer N, Casanova A, Bonnabau H, Platzer V, Tournier E, Sansas B, Verdun S, Thouvenot B, Hilselberger B, Doncescu A, Lamant L, Lacroix-Triki M, Favre G, Pradines A. Armand-Labit V, et al. Among authors: casanova a. Acta Derm Venereol. 2016 Jan;96(1):29-34. doi: 10.2340/00015555-2156. Acta Derm Venereol. 2016. PMID: 26039581 Free article.

6

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.

Delmas A, Cherier J, Pohorecka M, Medale-Giamarchi C, Meyer N, Casanova A, Sordet O, Lamant L, Savina A, Pradines A, Favre G. Delmas A, et al. Among authors: casanova a. Oncotarget. 2015 Jun 20;6(17):15250-64. doi: 10.18632/oncotarget.3888. Oncotarget. 2015. PMID: 26098773 Free PMC article.

7

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

Guibert N, Pradines A, Casanova A, Farella M, Keller L, Soria JC, Favre G, Mazières J. Guibert N, et al. Among authors: casanova a. J Thorac Oncol. 2016 Sep;11(9):e109-12. doi: 10.1016/j.jtho.2016.05.001. Epub 2016 May 7. J Thorac Oncol. 2016. PMID: 27165943 Free article. No abstract available.

8

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

Guibert N, Pradines A, Farella M, Casanova A, Gouin S, Keller L, Favre G, Mazieres J. Guibert N, et al. Among authors: casanova a. Lung Cancer. 2016 Oct;100:1-4. doi: 10.1016/j.lungcan.2016.07.021. Epub 2016 Jul 22. Lung Cancer. 2016. PMID: 27597273

9

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma.

Guibert N, Mazieres J, Delaunay M, Casanova A, Farella M, Keller L, Favre G, Pradines A. Guibert N, et al. Among authors: casanova a. Oncotarget. 2017 Jun 6;8(23):38056-38060. doi: 10.18632/oncotarget.16935. Oncotarget. 2017. PMID: 28445137 Free PMC article.

10

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

Keller L, Guibert N, Casanova A, Brayer S, Farella M, Delaunay M, Gilhodes J, Martin E, Balagué G, Favre G, Pradines A, Meyer N. Keller L, et al. Among authors: casanova a. Acta Derm Venereol. 2019 Feb 1;99(2):206-210. doi: 10.2340/00015555-3080. Acta Derm Venereol. 2019. PMID: 30393817 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters